Okay, I think I may understand what Oticon means when they say that in-situ works with your audiogram. In the audiogram/in-situ comparison that was linked above it says;
Results: At 500 and 1500 Hz, almost all threshold differences (conventional PTA minus in-situ data) were negative, i.e., in the low to mid frequencies, hearing loss was overestimated by most devices relative to PTA. At 4000 Hz, the majority of differences (7 of 12) were positive, i.e., in the frequency range above 1500 Hz, hearing loss was frequently underestimated. As hearing loss increased (M→MS→S), the effect of the underestimation decreased. At 500 and 1500 Hz, Resound devices showed the smallest threshold deviations, followed by Phonak, Starkey, and Oticon instruments. At 4000 Hz, this observed pattern partly disappeared and Starkey and Oticon devices showed a reversed effect with increasing hearing loss (M→MS→S). Because of high standard errors for the estimates, only a few explicit rankings of the devices could be established based on significant threshold differences (5% level).
In less scientific language, here’s what I think that means;
Results: At 500 and 1500 Hz, almost all threshold differences (audiogram minus in-situ data) were negative, i.e., in the low to mid frequencies, hearing loss was overestimated by (most devices/using in-situ) relative to the audiogram.
At 4000 Hz, the majority of differences (7 of 12) were positive, i.e., in the frequency range above 1500 Hz, hearing loss was frequently underestimated (using in-situ).
As hearing loss increased (M→MS→S), the effect of the underestimation decreased.
At 500 and 1500 Hz, (Resound devices/using in-situ) showed the smallest threshold deviations, followed by Phonak, Starkey, and Oticon instruments.
At 4000 Hz, this observed pattern partly disappeared and Starkey and Oticon devices (using in-situ) showed a reversed effect with increasing hearing loss (M→MS→S). Because of high standard errors for the estimates, only a few explicit rankings of the devices could be established based on significant threshold differences (5% level).
So here’s what I think the Oticon’s statement means; Since the manufacturers obviously know about the differences in (audiogram/in-situ) measurements based on low/high frequency, I think it simply means that Oticon in-situ considers the frequency measurement differences when producing the in-situ results. The other manufacturers may also make adjustments based on frequency? Who knows?
To summarize, I think it means nothing, except that Oticon uses an algorithm to calculate in-situ results as opposed to pure-tone only .